18956075901
當前位置：上海富雨生物科技有限公司>>細胞庫 / 細胞培養(yǎng)>>干細胞>> CZ-1人多發(fā)性骨髓瘤細胞、C
CZ-1 人多發(fā)性骨髓瘤細胞
Catalogue No.: C1318
Product Format: a 15 ml centrifuge tube
Culture Properties：懸浮
Complete Growth Medium: 89%1640+10%FBS+1%雙抗
Atmosphere: air, 95%; carbon dioxide (CO2), 5%
Application: Cells and cancer research
NOTE: FOR RESEARCH USE ONLY.
Components
| Item | Specifications |
| a 15 ml centrifuge tube | 2X106 |
| Manual | 1 copy |
The first monoclonal antibodies against the immune checkpoint programpkd death 1 (PD-1) receptor, nivolumab and pembrolizumab, are now approved for clinical use. Both agents are indicated for the treatpknt of advanced pklanoma, as well as for the treatpknt of pktastatic
請輸入賬號
請輸入密碼
請輸驗證碼
以上信息由企業(yè)自行提供，信息內容的真實性、準確性和合法性由相關企業(yè)負責，化工儀器網對此不承擔任何保證責任。
溫馨提示：為規(guī)避購買風險，建議您在購買產品前務必確認供應商資質及產品質量。
化工儀器網